With chronic urticaria on the rise, the CURE study calls for greater awareness on guideline-recommended classification, diagnostic workup, and treatment.

A global physician survey estimates chronic urticaria affects 2.5% of adults and highlights sleep, activity, and mental ...

Discover common skin care ingredients that can cause allergic reactions and learn how to identify them in your products. Chronic idiopathic urticaria, also known as chronic hives or chronic ...

Dupilumab improved HRQOL in patients with CSU who are omalizumab-naïve and have a substantial disease burden despite standard of care treatment.

(BPT) – If you’ve had hives, you know how challenging they can be. But you may not know that there is more than one type of hives, or urticaria, and that treatments are available. A brief episode of ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The Food and Drug Administration on Friday approved a ...

Dealing with six weeks or more of itchy, uncomfortable hives isn’t exactly a recipe for good mental health. Unfortunately, it’s the reality for people with chronic hives. Also known as chronic ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Chronic urticaria is an inflammatory skin disorder characterised by recurrent transient wheals and/or angioedema that persist for more than six weeks. Within this spectrum, chronic spontaneous ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade, drugmakers ...